English Polski

Wyszuk. zaawans.

Tom 3, Nr 3 (2010)
Sprawozdanie z konferencji / Sprawozdanie
Opublikowany online: 2010-10-05

dostęp otwarty

Pokaż PDF Pobierz plik PDF
Wyświetlenia strony 446
Wyświetlenia/pobrania artykułu 2169
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Problemy zarządzania jakością

Aleksandra Dzieciątkowska
Journal of Transfusion Medicine 2010;3(3):123-129.

Streszczenie

Brak

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Vuk T. Skills and tasks of quality manager at a blood establishment. ISBT Science Series. 2010; 5(n1): 179–183.
    CrossRef
  2. Slopecki A. Do I assist or supervise? Achievements of quality management implementation. ISBT Science Series. 2010; 5(n1): 184–189.
    CrossRef
  3. Cheng S, Lin CK, Lee CK, et al. Integrated quality-environmental-health and safety management system in blood transfusion service, Hong Kong. Vox Sang. 2010; 99(supl. 1): 56.
  4. Aarewatte PA. P.M. A step forward in regularizing hospital transfusion committees of all hospitals in Sri Lanka. Vox Sang. 2010; 99(supl. 1): 57.
  5. Wesche J, Greinacher A, Hammer E, et al. Characterisation of the human neutrophil antigen HNA 3A. Vox Sang. 2010; 99(supl. 1): 6.
  6. Murphy E, Kwaan N, Paulukonis S, et al. Transfusion associated circulatory overload (TACO): risk factors and mortality. Vox Sang. 2010; 99(supl. 1): 7.
  7. Addas-Carvalho M, Gontijo T, Nascimento RA, et al. D. Active haemovigilance: an efficient mechanism for identification of acute transfusion reactions (ATR) unreported. Vox Sang. 2010; 99(supl. 1): 7.
  8. Nguyen D, Dengler T, Gobel M, et al. Detection of granulocyte-specific antibodies in blood donors using automated high throughput screening methods: flow-GIFT. Vox Sang. 2010; 99(supl. 1): 8.
  9. Reil A, Manke D, Schleif G, et al. Geno- and phenotyping of HNA-3A and HNA-3B. Vox Sang. 2010; 99(supl. 1): 8.
  10. Pasini EM, Lutz HU, Mann M, et al. Proteomics, the red blood cell and transfusion medicine. Vox Sang. 2010; 5: 63–72.
  11. Antoniewicz-Papis J, Wozniak J, Krzywdzinska A, et al. Lymphocyte survival/activation in stored platelet concentrates following gamma-irradiation or pathogen reduction technology treatment. Vox Sang. 2010; 99(supl. 1): 18.
  12. Bohonek M, Kostouchova B, Petras M, et al. Quality evaluation of blood components manufactured by using a hollow-fibre separation technology. Vox Sang. 2010; 99(supl. 1): 18.
  13. Yedgar S, Koshkaryev A, Relevy H, et al. Monitoring of red blood cell (RBC) flow properties for quality control of bloodbanked RBC, and treatments for improving their transfusion outcome. Vox Sang. 2010; 99(supl. 1): 19.
  14. Shabayek S, Morftah F, Ahmed A. Developing error management culture in Egyptian NBTS. Vox Sang. 2010; 99(supl. 1): 19.
  15. Schärer C. Good practice in plasma collection and fractionation. Vox Sang. 2010; 5(n1): 95–98.
    CrossRef
  16. Dodt WM. Documentation of quality; the plasma master file. Vox Sang. 2010; 99(supl. 1): 29.
  17. Schramm G. Optimal use of blood products: proceedings of an EDQM meeting in Wildbad Kreuth. Vox Sang. 2010; 99(supl. 1): 29.
  18. Salama A. Differential diagnosis and treatment of immune hemolytic anemias. Vox Sang. 2010; 99(supl. 1): 54.
  19. Olsson ML. Orphan and emerging blood groups. Vox Sang. 2010; 99(supl. 1): 54.
  20. Poole J, Thornton NM, Tilley L, et al. Novel high incidence antigen in the Diego blood group system (DISK) and clinical significance of anti-DISK. Vox Sang. 2010; 99(supl. 1): 54–55.
  21. von Za, Wagner FF, Flegel WA. Ten years Rhesus Immunization Registry. Vox Sang. 2010; 99(supl. 1): 55.
  22. Thuresson B, Westman J, Jould M, et al. P 1 /P 2 -specific polymorphism found in a novel A4GALT transcript: the missing link between P K and P1 histo-blood group antigens. Vox Sang. 2010; 99(supl. 1): 55.
  23. Veldhuizen IJ. T. “Thank you! Please visit us again”. Reflecting on the donor retention literature — implications for retention practices. Vox Sang. 2010; 5: 196–200.
  24. de Ko. Donor management: DOMAINE — the European perspective. Vox Sang. 2010; 5: 201–205.
  25. Benjamin RJ. Donor hemovigilance: safety as the first priority of blood donor management. ISBT Science Series. 2010; 5(n1): 206–211.
    CrossRef
  26. Radtke H, Mayer B, Salama A. Iron depletion in blood donors: does it matter? Vox Sang. 2010; 99(supl. 1): 60.
  27. Greinacher A, Fendrich K, Hoffmann W. Demographic changes: the impact for safe blood supply. ISBT Science Series. 2010; 5(n1): 239–243.
    CrossRef
  28. Stutzer A, Goette L. Blood donor motivation: what is ethical? What works? Vox Sang. 2010; 5: 244–248.
  29. Klein H. Testing for pathogens: the importance of international standards. Vox Sang. 2010; 99(supl. 1): 74.
  30. Heiden M, Seitz R. Pathogen inactivation — regulators aspects. Vox Sang. 2010; 5: 279–281.
  31. Bergman E, Davis RIT. and informatics in translational research: a case study. Vox Sang. 2010; 5: 303–307.
  32. Bruce P. New it guidelines from the ISBT and what’s next on the agenda of the WPIT. Vox Sang. 2010; 99(supl. 1): 84.
  33. Simon I. Development and implementation of an on-line ordering and receipting blood system (ORBS). Vox Sang. 2010; 99(supl. 1): 84.
  34. Zaky M. Egyptian experience of NBTS staff in literacy and training on computerized blood transfusion services activities. Vox Sang. 2010; 99(supl. 1): 84–85.
  35. Bahovadino B. Results of blood service reform in Tajikistan. Vox Sang. 2010; 99(supl. 1): 136.
  36. Fretz C, Sanou M, Nebie Y, et al. Qality management system in blood establishments in a sub Saharan country: Burkina Faso. Vox Sang. 2010; 99(supl. 1): 143.
  37. Durro V. The organization of a quality system in blood transfusion service in Albania. Vox Sang. 2010; 99(supl. 1): 145.
  38. Huang YY. The common errors of blood banks in ISO 15189 accreditation in Taiwan. Vox Sang. 2010; 99(supl. 1): 133–134.
  39. Marcovic A, Weinstock C. Auditing the upper management — important, but not a matter of course. Vox Sang. 2010; 99(supl. 1): 141.
  40. Sarlija D, Stimac R, Jukic IA. new method of monitoring corrective actions required by internal quality audits at Croatian Institute of Transfusion Medicine (CITM). Vox Sang. 2010; 99(supl. 1): 142.
  41. Farmaki K, Tzoumari I, Savvanos M, et al. Blood transfusion service certification for the new ISO 9001:2008. Vox Sang. 2010; 99(supl. 1): 144.
  42. Ambriz-Fernandez R, Rivera-Lopez R, Portillo ML, et al. Blood donation waiting time obtained by automated standards in Mexico. Vox Sang. 2010; 99(supl. 1): 135.
  43. Speletz H, Lanzer G, Wagner T. From vein to vein: tracking and temperature monitoring of blood bags with help of RFID technology. Vox Sang. 2010; 99(supl. 1): 136–137.
  44. Zhao LA. comparative analysis of testing results of alanine aminotransferase on different detecting systems. Vox Sang. 2010; 99(supl. 1): 137.
  45. Cellier N, Goossens D, Lambermont M, et al. Implementation of metrology in the SFS (Service Francophone du Sang, Belgium). Vox Sang. 2010; 99(supl. 1): 137–138.
  46. Schennach H, Mair-Enzi N, Pahle U, et al. Experience with sterile docking device 1-BB-SK-40-E-VT in reducing false positive results for bacterial screening of platelet concentrates. Vox Sang. 2010; 99(supl. 1): 138.
  47. Mada T, Takano H, Ishii Y, et al. Quality control test for blood bags at the Japanese Red Cross Society. Vox Sang. 2010; 99(supl. 1): 140–141.
  48. Singh H. Process excellence and performance enhancement: beyond technical and design excellence. Vox Sang. 2010; 99(supl. 1): 141.
  49. Qaglietta A, Bonfini T, Capone A, et al. Validation of a pneumatic tube system for transportation of blood components and blood test tubes. Vox Sang. 2010; 99(supl. 1): 142.
  50. Ramoa A, Oliveira N, Ramoa P, et al. TACI — Internal communications support technology. Vox Sang. 2010; 99(supl. 1): 143.
  51. Rapaille A, Guillet A, Deneys V, et al. Blood component production statistical process control in Service du Sang — Belgian Red Cross. Vox Sang. 2010; 99(supl. 1): 134.
  52. Chartois-Leaute AG, Chabanel A, Folea G. National French external quality assessment for enumeration of residual leucocytes by flow cytometry: a 5 year experience. Vox Sang. 2010; 99(supl. 1): 137.
  53. Adicarama B. Analysis of quality parameters of red cell concentrates (RCC) prepared by two different methods at National Blood Center (NBC) Sri Lanka. Vox Sang. 2010; 99(supl. 1): 138–139.
  54. Bosanac J. Multicentric quality assessment of antibody screening and identification in immunohematology testing in Croatia 1993–2009 period. Vox Sang. 2010; 99(supl. 1): 134.
  55. Mohsen M, Moftah F, Goubran H. The continuous program — a tool towards improvement. Vox Sang. 2010; 99(supl. 1): 139.
  56. Garcia-Bernardo M, Coelho H, Fernandes P, et al. Analysis of quality indicators in the Coimbra Regional Blood Center. Vox Sang. 2010; 99(supl. 1): 139–140.
  57. Mohamadi MT, Abolghasemi H, et al. Nicougoftar Zarif M. Evaluation of CD45 positive cells count for detection of residual leukocytes in leukodepleted blood products. Vox Sang. 2010; 99(supl. 1): 140.
  58. Yu Y, Ma CY, Feng X, et al. Preparation and evaluation of internal quality control products for blood transfusion compatibility testing. Vox Sang. 2010; 99(supl. 1): 141–142.
  59. Khandhedia D, Andipara N, Sawant R. Quality system for ELISA testing in blood bank. Vox Sang. 2010; 99(supl. 1): 143.
  60. Lusinanto A, Suyati MF, Nur Ad, et al. Evaluation of reagent quality control section Central Blood Transfusion Service Indonesian Red Cross years 2004–2009. Vox Sang. 2010; 99(supl. 1): 144–145.
  61. Aghahoseini M, Akbari N, Hariri MM, et al. Reporting of actual and near-miss events for improving transfusion safety in Isfahan Blood Transfusion Organization. Vox Sang. 2010; 99(supl. 1): 135.
  62. Bahovadino B, Muratov A, Tretyakova A, et al. Prophylactic methods of post transfusion haemolitic complications in medical treatment institutions in Tajikistan. Vox Sang. 2010; 99(supl. 1): 135–136.
  63. Pirc-Tiljak DP. T. To err is human, to confess is never too late. The case report of haemovigilance in praxis. Vox Sang. 2010; 99(supl. 1): 144.
  64. Jones E, Gray A, Inglis G, et al. Developing an elearning module to support GMP training in hospital transfusion laboratories. Vox Sang. 2010; 99(supl. 1): 134–135.
  65. Bogdanovic S, Bujandric N. Prevention of blood transmitted infections among health care professionals in the Blood Transfusion Institute of Vojvodina. Vox Sang. 2010; 99(supl. 1): 139.

Informacje o plikach cookie

Niezbędne pliki cookie

Zawsze aktywne

Te pliki cookie są niezbędne do prawidłowego wyświetlania i działania strony internetowej. Zablokowanie ich może spowodować nieprawidłowe działanie strony.

Analityczne pliki cookie

W ramach naszej strony internetowej korzystamy z narzędzi analitycznych, takich jak Google Analytics, które umożliwiają nam weryfikację ruchu na stronie internetowej. Narzędzia te mogą wymagać użycia plików cookie.

Społecznościowe pliki cookie

Są to pliki cookie powiązane z portalami społecznościowymi, z których korzystamy. Zaakceptowanie ich pozwoli na powiązanie Twojej wizyty na stronie z naszymi profilami w mediach społecznościowych.

Marketingowe pliki cookie

Są to pliki cookie odpowiedzialne za prowadzenie działań reklamowych i marketingowych - zgoda na ich wykorzystanie pozwoli nam kierować do Ciebie reklamy, bazujące na podstawie Twoich wcześniejszych aktywności w ramach naszej stronie internetowej.

Copyright © 2023-2024 Via Medica Regulamin Polityka cookies Polityka prywatności Nota prawna